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Abstract
Background: The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a commonly used knee assessment and
outcome tool in both clinical work and research. However, it has not been formally translated and validated in
Finnish. The purpose of this study was to translate and culturally adapt the KOOS questionnaire into Finnish and to
determine its validity and reliability among Finnish middle-aged patients with knee injuries.
Methods: KOOS was translated and culturally adapted from English into Finnish. Subsequently, 59 patients with
knee injuries completed the Finnish version of KOOS, Western Ontario and McMaster Osteoarthritis Index (WOMAC),
Short-Form 36 Health Survey (SF-36) and Numeric Pain Rating Scale (Pain-NRS). The same KOOS questionnaire was
re-administered 2 weeks later. Psychometric assessment of the Finnish KOOS was performed by testing its construct
validity and reliability by using internal consistency, test-retest reliability and measurement error. The floor and
ceiling effects were also examined.
Results: The cross-cultural adaptation revealed only minor cultural differences and was well received by the
patients. For construct validity, high to moderate Spearman’s Correlation Coefficients were found between the
KOOS subscales and the WOMAC, SF-36, and Pain-NRS subscales. The Cronbach’s alpha was from 0.79 to 0.96
for all subscales indicating acceptable internal consistency. The test-retest reliability was good to excellent, with Intraclass
Correlation Coefficients ranging from 0.73 to 0.86 for all KOOS subscales. The minimal detectable change ranged from 17
to 34 on an individual level and from 2 to 4 on a group level. No floor or ceiling effects were observed.
Conclusion: This study yielded an appropriately translated and culturally adapted Finnish version of KOOS
which demonstrated good validity and reliability. Our data indicate that the Finnish version of KOOS is
suitable for assessment of the knee status of Finnish patients with different knee complaints. Further studies are
needed to evaluate the predictive ability of KOOS in the Finnish population.
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Background
Knee pain is common complaint affecting people of all
ages. In adult populations, the reported prevalence of knee
pain has been 25–28% depending on the age of the exam-
ined persons and the level of pain chronicity [1–3]. In the
younger age groups, knee pain is commonly secondary to
increased activity, injury or contact sports [4–6]. In older
people, however, knee pain that gets progressively worse
over time is often sign of osteoarthritis (OA) [7, 8]. Knee
OA in particular is associated with severe disability, owing
to the weight-bearing function of the knee and the large
range of movements it performs.
To be able to detect and treat individuals with a var-
iety of knee problems effectively requires reliable and
valid outcome measures, preferably at low cost. During
recent decades, a few well-validated outcome measures
have been developed for the assessment of symptoms
and function in subjects with knee or hip OA [9–11]. In
the elderly population, the Western Ontario and
McMaster Osteoarthritis Index (WOMAC) is the
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self-administered instrument most commonly used to
measure pain, stiffness and function in daily living. How-
ever, in younger and/or more physically active subjects,
joint injuries cause knee problems more often than pri-
mary knee OA per se. Younger patients also often have
higher expectations regarding physical functioning.
Thus, the WOMAC may not be appropriate for these
subjects. Partly for this reason, the Knee injury and
Osteoarthritis Outcome Score (KOOS) was developed
in the late 1990s as an extension of the WOMAC
index to address problems associated with knee injur-
ies and/or knee OA [12].
KOOS is a disease-specific, patient-reported outcome
(PRO) measure assessing perceived pain, other symp-
toms, activities of daily living, sport and recreation func-
tions, and knee-related quality of life. It is freely
accessible, and intended for use over the short- and
long-term for both research and clinical purposes.
KOOS has been found to be a valid, reliable and respon-
sive outcome measure in different patient populations
with varying knee injuries (of menisci, ACL or cartilage)
[13, 14], knee OA [15–19] and total knee replacement
[20]. Currently, KOOS is available in 50 different lan-
guages and language variants [21]. However, the validity
and reliability of the Finnish version of KOOS in sub-
jects with different knee problems or OA have not been
previously reported. Hence, the purpose of this study
was to produce a Finnish version of KOOS and to evalu-
ate its construct validity and reliability in a sample of
middle-aged patients with knee injuries.
Methods
Cross-cultural adaptation
Prior to the implementation of the KOOS questionnaire,
a cross-cultural adaptation of the measure was per-
formed in accordance with the recommendations by
Beaton et al. (2000) [22]. The American-English KOOS
[12] was translated into Finnish by two translators inde-
pendently, one translator was an experienced orthopedic
surgeon (T1) and the other a professional translator with
no medical background or special knowledge of the con-
cepts in question (T2). Both versions were then collated
in a consensus meeting. This consensus version was
translated back into English independently by two
Finnish-speaking translators of English origin (BT1 and
BT2) unfamiliar with the original questionnaire or con-
cepts therein. The translations into Finnish and back
translations into English were thereafter discussed and
collated in a second consensus meeting. This version
was then pre-tested with 16 postmenopausal women
with mild knee OA to confirm if all the items in the
questionnaire were understandable and whether the sub-
jects experienced problems in answering any of them.
Patients and data acquisition
The study population comprised patients with diverse
knee problems, including OA, post-traumatic injuries,
meniscus and ligament problems. The patients had been
referred to the Department of Orthopedics and Trauma-
tology in Helsinki University Hospital from primary
health care centers in the Hospital District of Helsinki
and Uusimaa, where, based on clinical and radiographic
or Magnetic Resonance Imaging findings, they were
diagnosed as having OA or Anterior Cruciate Ligament
(ACL), meniscus or combined ACL and meniscus injur-
ies. For this study, all the assessed patients had to be in
a clinically stable condition and not expected to undergo
urgent surgery. The patients were recruited between
March 2014 and May 2015 using a systematic sampling
technique. The inclusion criteria were age 18 years or
over, unresponsive to conservative treatment, and the
ability to communicate in written Finnish. Eligible pa-
tients were informed about the study, and indicated their
willingness to participate by giving their informed con-
sent. For test-retest purposes, the participants were
asked to complete KOOS twice: first, during the hospital
visit, and then again 2 weeks later at home. During the
hospital visit the patients were asked to fill in the KOOS
along with the WOMAC, the SF-36 and the Numeric
Rating Scale of Pain forms. One hundred thirty-one pa-
tients completed all four questionnaires during the hos-
pital visit. Of these patients, 59 returned the KOOS
questionnaire 2 weeks later from home by regular mail
in a pre-paid envelope, yielding a sample of 59 pa-
tients for the study. The local Medical Ethics Com-
mittee of Helsinki University Hospital approved the
study plan (Approval number 37/13/03/02/2014).
Written informed consents were obtained and partici-
pants’ rights protected.
Questionnaires
KOOS
KOOS is a patient-administered knee-specific question-
naire comprising five subscales: Pain (nine items); Symp-
toms (seven items); Activities of Daily Living (ADL) (17
items); Sport and Recreation (five items); and
Knee-Related Quality of Life (QOL) (four items). Each
item is scored from 0 (best) to 4 (worst) using a Likert
type scale with 5 boxes. The raw score for each subscale
is the sum of the item scores. Scores are then trans-
formed to a 0 to 100 scale. The scores of the five sub-
scales can be expressed as an outcome profile, higher
scores indicating fewer problems. A total score has not
been validated and is not recommended according to
the KOOS Users Guide [21]. When filling the question-
naire the subjects are instructed to consider the previous
week when answering the questions. The KOOS has a
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self-explanatory format and the questionnaire takes
about 10 min to complete [12].
WOMAC
The Western Ontario and McMaster Osteoarthritis
Index (WOMAC) is a disease-specific, self-administered
health status instrument assessing pain, stiffness, and
function in subjects with OA of the hip or knee [10].
The index consists of 24 questions in three dimensions:
knee pain (5 questions), joint stiffness (2 questions) and
functional ability (17 questions). These dimensions are
often analyzed and reported separately, but the
WOMAC index can also be aggregated into a single
score. The original WOMAC is available in two formats:
Visual Analog Scales (VAS) and Likert-boxes. In this
study, we used the VAS format (0–100 mm), where the
sum of the raw scores was transformed to a 0–100 scale.
Higher scores indicate a higher level of joint pain, joint
stiffness and functional limitation. For this study, how-
ever, to allow comparison between the KOOS and
WOMAC outcomes, we reversed the scoring direction
of the WOMAC outcomes, meaning that higher scores
indicate decreased pain, joint stiffness and functional
limitation. WOMAC has been extensively tested for reli-
ability, validity and responsiveness in different countries
[23]. The Finnish version of WOMAC has been vali-
dated for the short- and long-term follow-up of patients
scheduled for total knee or hip arthroplasty [24].
SF-36
Health-related quality of life was measured using the
Short-Form 36 Health Survey (SF-36) [25]. SF-36 is a
generic survey comprising 8 distinct dimensions of
health status: Physical Functioning, General Health, Vi-
tality, Mental Health, Role- Physical, Role-Emotional,
Social Functioning and Bodily Pain. The scale runs from
0 to 100 in each dimension, with a higher score indicat-
ing better health.
Pain-NRS
The subjective intensity of pain in general and in differ-
ent body regions was measured on the numeric pain rat-
ing scale (Pain-NRS). The body regions in this study
were neck, back, upper limb, lower limb and knee. The
Pain-NRS is an 11-point scale ranging from 0 to 10,
where 0 represents “no pain” and 10 represents “the
most intense pain imaginable”. For this study, however,
as with WOMAC we reversed the scoring direction of
the Pain-NRS outcomes, meaning that higher scores in-
dicate “no pain” and lower scores indicate “the most in-
tense pain imaginable”. When filling the form, patients
are asked to select the value that best describes the in-
tensity of pain that they have experienced during the
past week.
Background data
During their visit to the outpatient clinic, in addition to
demographic data, patients were asked for anamnestic
information regarding their knee problem, and to de-
scribe the intensity of their habitual physical activity
(low = 1, moderate = 2, or high = 3–4).
Assessment of psychometric properties
Construct validity was determined by comparing the
first administration of the five KOOS subscales against
the five WOMAC subscales, the eight SF-36 subscales,
and the six Pain-NRS subscales. On the assumption that
the highest correlations can be expected to be observed
when comparing scales that are intended to measure the
same or similar constructs, we posited a priori sets of
hypotheses about convergent relationships between
physical health properties which are given in Table 4 in
the results section. We defined the construct validity of
the KOOS questionnaire as good if at least 75% of the
hypotheses could be supported [26]. The internal
consistency of the first-administered KOOS was deter-
mined by defining the degree of inter-relatedness among
the items. Test-retest reliability was determined by com-
paring the scores of the first- and second-administered
KOOS questionnaires. Measurement error is the system-
atic and random error of a patient’s score that is not at-
tributed to true changes in the construct to be measured
[27]. The standard error of measurement (SEM) is a
measure of the absolute measurement error of how
much measured test scores tend to be distributed
around a “true” score. SEM is expressed in the unit of
measurement of the instrument. The minimal detectable
change (MDC), in turn, is the threshold for determining
clinical changes outside measurement error. The floor
and ceiling effect of the KOOS was also examined. We
checked each questionnaire for missing values prior to
further analysis. The KOOS Users Guide 2012 rule was
applied for missing items [21].
Statistical analyses
Quantitative variables are described using mean and
standard deviation (SD) or median and interquartile
range (IQR) values, and categorical variables are de-
scribed using frequency and percentage values. Con-
struct validity was calculated by using Spearman’s
correlation coefficient to assess the relationships be-
tween the KOOS subscales and the WOMAC, SF-36
and numeric pain rating scales. Correlation coefficients
less than 0.2 were considered very weak, between 0.2
and 0.39 weak, between 0.4 and 0.59 moderate, between
0.6 and 0.79 strong, and above 0.79 very strong [28].
Internal consistency was determined by calculating
Cronbach’s α coefficient. A Cronbach’s α equal to, or
greater than, 0.70 is generally regarded as acceptable for
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internal consistency [29, 30]. Test-retest reliability, indi-
cating the consistency of the KOOS scores between the
first and second administration of the questionnaire, was
calculated using the two-way random effect model of
the intraclass correlation coefficient (ICC) presented
with 95% confidence intervals (CI). ICC values above
0.81 were interpreted as excellent, whereas values be-
tween 0.80 and 0.61 indicated good, values between 0.60
and 0.41 moderate, values between 0.40 and 0.21 fair,
and values below 0.20 low reliability [31]. SEM was
calculated using the formula: SEM = 1.96√(1-R), where
1.96 derives from the 0.95% CI and R represents the
calculated ICC coefficient. MDC was calculated using
the formula: MDC = SEM*1.96√2, where 2 represents two
measurements evaluating the change [32]. For group
comparison the MDC can be calculated, depending on the
size of the group (n = 59), as follows:
MDCgroup = MDCindividual/√n [33]. The floor and
ceiling values representing the percentages of the pa-
tients who obtained the lowest or highest scores were
calculated for each KOOS subscale separately. Floor
and ceiling effects are considered present if more than
15% of the respondents achieve the lowest or highest
possible scores [26].
Results
Patients
A total of 59 patients were included in the validity, in-
ternal consistency, test-retest, measurement error and
floor/ceiling effects assessments. Mean participant age
was 49 (SD 14), most were women (78%), and the me-
dian duration of knee symptoms was 7 months for
women (IQR 4, 12) and 6 months for men (IQR 3, 18).
Mean self-reported knee pain for all patients was 5.6
(SD 2.6) on a NRS scale of 0 to 10. The characteristics
of the study population are presented in Table 1.
Only a few individual items (2%), all from the Pain and
Sport and Recreation Function subscales, were missing,
and hence a total score for all the subscales was available
for all patients (Table 2). The lowest possible scores were
reported by 5 (9%) patients for the subscale Sport and
Recreation Function and by 4 (7%) patients for the sub-
scale QOL. The best possible scores were reported by
one patient (2%) for the subscales Pain and QOL, and by
2 patients (3%) for the subscales ADL and Sport and Re-
creation Function (Table 2).
Cross-cultural adaptation
The cross-cultural adaptation revealed minor cultural
differences. In the subscale Activities of Daily Living,
items A9 and A11 (“Putting on socks/stockings”, and
“Taking off stocks /stockings”) the word “stockings” was
omitted. In addition, item A13 on the same subscale
(“Getting in/out of the bath”) the word “shower” was
added as an alternative to bath. The Finnish version of
the KOOS questionnaire was well received by the sam-
ple of 16 postmenopausal women with mild knee OA.
All the questions and response options were considered
understandable and applicable. The back-translation of
the Finnish version of the KOOS questionnaire is avail-
able in the additional file [see Additional file 1].
Construct validity
Overall, the highest correlations were found between the
KOOS subscales and WOMAC subscales. As shown in
Table 3, all the KOOS and WOMAC subscales corre-
lated significantly, with values of r within the range 0.33
to 0.86. The highest correlations were between the sub-
scales intended to measure similar constructs (KOOS
ADL vs. WOMAC Physical function, r = 0.86; KOOS
Pain vs. WOMAC Pain, r = 0.81). In addition, the KOOS
Symptoms and WOMAC Stiffness subscales correlated
moderately (r = 0.48). Thus, the set of a priori hypoth-
eses posited for KOOS and WOMAC was supported
(Table 4).
Table 1 Demographic and clinical characteristics of patients
Variables Values
Women, n (%) 46 (78)
Age, mean (SD) 49 (14)
Body mass index, mean (SD) 26.5 (4.9)
≥30, n (%) 13 (22)
Employment status, n (%)
Employed 41 (69)
Unemployed 8 (14)
Retired 10 (17)
White collar workers, n (%) 28 (47)
Duration of symptoms, month, median (IQR) 6 (3, 12)
Onset of knee pain, n (%)
Accidentally 27 (46)
No clear event 32 (54)
Leisure time physical activity, n (%)
Low 8 (14)
Moderate 27 (46)
High 24 (40)
Numeric Pain Rating Scale (0 to 10 scale)a, mean (SD)
General 4.5 (2.3)
Neck 2.6 (2.5)
Back 2.4 (2.5)
Upper limb 1.9 (2.6)
Lower limb 3.9 (3.1)
Knee 5.6 (2.6)
SD Standard Deviation, IQR Interquartile Range
anegative number indicates less pain
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Higher correlations were found for the KOOS scales
and the SF-36 scales, indicating their high ability to
measure physical health, i.e., Physical Functioning,
Role-Physical, and Bodily Pain (Table 3). As with
WOMAC, the highest correlation between KOOS and
SF-36 was found between the subscales intended to
measure similar constructs (KOOS Pain vs. SF-36 Bodily
Pain, r = 0.69; KOOS ADL vs. SF-36 Physical Function-
ing, r = 0.83). The KOOS Sport and Recreation Function
and SF-36 Physical Functioning subscales also correlated
strongly (r = 0.67), thus supporting the set of a priori hy-
potheses posited for KOOS and SF-36 (Table 4). The
correlations between the KOOS subscales and the SF-36
dimensions of General Health, Vitality, Mental Health,
Role-Emotional and Social Functioning, were lower, in-
dicating the KOOS’s ability to measure rather physical
than mental health.
The highest correlations between the KOOS and
Pain-NRS subscales pertaining to different regions of the
body were found for the knee area (r = 0.46–0.68) and
lower limbs (r = 0.37–0.61) (Table 3). In addition, overall
general pain showed moderate correlations with most of
the KOOS subscales. The hypotheses of a strong
correlation between KOOS ADL and Pain-NRS Knee
(r = 0.68), and moderate correlation between KOOS
QOL and Pain-NRS Knee (r = 0.53) were both sup-
ported. However, KOOS Pain and Pain-NRS Knee
showed strong correlation (r = 0.66) instead of expected
very strong correlation (Table 4).
Reliability
The mean change in the second measurement varied
from − 0.7 in the Symptoms subscale to 8.7 in the Sport
and Recreation Function subscale (Table 5).
Internal consistency
Cronbach’s α ranged from 0.79 to 0.96, indicating good
internal consistency in all the KOOS subscales (Table 5).
Test-retest reliability
The test-retest reliability of the KOOS was excellent for
the Pain, ADL and Knee-related Quality of Life sub-
scales, with ICCs ranging from 0.83 to 0.86. In the
Symptoms and Sport and Recreation Function subscales,
reliability was good, with ICCs (95% CIs) of 0.73 (0.59 to
0.83) and 0.72 (0.57 to 0.82), respectively (Table 5).
Measurement error
The SEM values ranged from 6.0 to 12.2, with the lowest
for the Symptoms subscale and highest for the Sport and
Recreation Function subscale (Table 5). Correspondingly,
Table 2 Mean scores, response rates and floor and ceiling percentages for the Finnish KOOS subscales
Mean (SD) Response rate (%) Floora (%) Ceilingb (%)
Pain 55.4 (22.3) 98 0 2
Symptoms 53.3 (13.4) 100 0 0
Activities of Daily Living 67.4 (23.0) 100 0 3
Sport and Recreation Function 32.9 (25.9) 98 9 3
Knee-related Quality of Life 32.3 (22.5) 100 7 2
100 = no knee problems, 0 = extreme knee problems
KOOS Knee Injury and Osteoarthritis Outcome Score, SD Standard Deviation
aWorst possible value on the subscale
bBest possible value on the subscale
Table 3 Spearman’s correlation coefficients for comparisons of
the five KOOS subscales with the three WOMAC subscales, eight
SF-36 subscales, and the six Pain-NRS subscales
KOOS
Pain
KOOS
Symptoms
KOOS
ADL
KOOS
Sport/Rec
KOOS
QOL
WOMAC
Pain 0.81 0.37 0.65 0.52 0.54
Stiffness 0.60 0.48 0.79 0.62 0.46
Physical function 0.75 0.33 0.86 0.72 0.63
SF-36
Physical Functioning 0.70 0.43 0.83 0.67 0.66
General Health 0.11 0.25 0.39 0.13 0.10
Vitality 0.28 0.24 0.43 0.18 0.19
Mental Health 0.12 0.15 0.33 0.06 0.08
Role-Physical 0.39 0.34 0.58 0.36 0.30
Role-Emotional 0,41 0.22 0.60 0.29 0.23
Social Functioning 0.42 0.29 0.64 0.41 0.30
Bodily Pain 0.69 0.46 0.77 0.58 0.51
Pain-NRS
General 0.42 0.23 0.48 0.44 0.53
Back 0.19 0.17 0.37 0.16 0.33
Lower limb 0.37 0.37 0.61 0.41 0.37
Neck 0.09 0.05 0.35 0.07 0.21
Upper limb 0.18 0.39 0.57 0.28 0.33
Knee 0.66 0.46 0.68 0.50 0.53
All correlations over 0.27 were significant at 0.05 level; N = 59
KOOS Knee Injury and Osteoarthritis Outcome Score, ADL Activities of Daily
Living, Sport/Rec Sport and Recreation Function, QOL Quality of Life, WOMAC
Western Ontario and McMaster Osteoarthritis Index, SF-36 Short-Form 36
Health Survey, Pain-NRS Numeric Pain Rating Scale
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at the individual level the MDC was lowest (16.6) for the
Symptoms subscale and highest (33.8) for the Sport and
Recreation Function subscale. At the group level, MDC
ranged between 2.2 and 4.4 (Table 5).
Discussion
This study reports on the cross-cultural adaptation and
translation of KOOS into Finnish and its reliability, con-
struct validity and floor/ceiling effects in patients with
knee injuries and/or OA. The results indicated that the
Finnish version of KOOS has good construct validity,
and that the questionnaire is a reliable measure of pain,
symptoms, activities of daily living, sport and recreation,
and quality of life in Finnish-speaking patients with knee
injuries of different kinds.
The psychometric properties of the Finnish version of
KOOS were in line with those of the original KOOS [13,
34, 35] and with the Persian version of KOOS [14],
which studied a group of patients with knee injuries,
similar to those in the present study, although not in-
cluding knee OA. The mean scores for the Sport and
Recreation Function and QOL subscales were consider-
ably lower than the scores for the other subscales, as
previously reported [12, 15, 16, 34, 36]. The likely reason
for these low values, especially for the Sport and Recre-
ation Function, is that knee injury patients tend to avoid
risky activities in their daily lives. The present study
demonstrated neither floor nor ceiling effects, as the
proportion of worst or best possible percentage scores
for the KOOS subscale with the highest scores was only
9%. This demonstrates the appropriateness and compre-
hensiveness of the questionnaire for a patient population
with relatively moderate knee pain and other knee injury
symptoms.
The construct validity of the KOOS was determined
by comparing the KOOS subscales with the subscales of
the WOMAC, SF-36 and Pain-NRS. The KOOS sub-
scales are as representative as those of the WOMAC for
measuring pain, stiffness and function. It was therefore
expected that strong or very strong correlations between
the KOOS and WOMAC subscales would be found.
However, in interpreting these coefficients it must be ac-
knowledged that all these measurements overlap to a
certain extent. The WOMAC Pain items are included in
the KOOS subscale of Pain, the WOMAC Stiffness items
are included in the KOOS subscale of Symptoms, and
the WOMAC Physical Function items are identical to
the KOOS ADL items. Thus, in the latter, the subscale
Table 4 A priori hypotheses of the expected correlations and realized correlations between the KOOS subscales and the subscales
of the WOMAC, SF-36 and Pain-NRS. The correlations are given as Spearman’s correlation coefficient (r) values
Comparative subscales Expected correlation Realized correlation
KOOS Pain WOMAC Pain r = > 0.79 (very strong) r = 0.81, supported
KOOS Symptoms WOMAC Stiffness r = 0.40 to 0.79 (moderate - strong) r = 0.48, supported
KOOS ADL WOMAC Physical function r = > 0.79 (very strong) r = 0.86, supported
KOOS Pain SF-36 Bodily Pain r = 0.60 to 0.79 (strong) r = 0.69, supported
KOOS ADL SF-36 Physical Functioning r = > 0.79 (very strong) r = 0.83, supported
KOOS Sport/Rec SF-36 Physical Functioning r = 0.60 to 0.79 (strong) r = 0.67, supported
KOOS Pain Knee Pain-NRS r = > 0.79 (very strong) r = 0.66, not supported
KOOS ADL Knee Pain-NRS r = 0.60 to 0.79 (strong) r = 0.68, supported
KOOS QOL Knee Pain-NRS r = 0.40 to 0.59 (moderate) r = 0.53, supported
KOOS Knee Injury and Osteoarthritis Outcome Score, WOMAC Western Ontario and McMaster Osteoarthritis Index, SF-36 Short-Form 36 Health Survey, Pain-NRS
Numeric Pain Rating Scale, ADL Activities of Daily Living, Sport/Rec Sport and Recreation Function, QOL Quality of Life
Table 5 Difference between first and second measurement, internal consistency, test-retest reliability, and measurement error of the
KOOS subscales
Change from first to
second measurement
Internal
consistency
Test-retest
reliability
Measurement error
Mean
(95% CI)
Cronbach’s α
(95% CI)
ICC
(95% CI)
SEM
(95% CI)
MDC (95% CI)
in individuals
MDC (95% CI)
in groups
Pain 2.8 (−0.3 to 5.9) 0.89 (0.84 to 0.94) 0.86 (0.77 to 0.91) 7.7 (5.8 to 9.6) 21.3 (16.5 to 25.1) 2.8 (2.2 to 3.4)
Symptoms −0.7 (−3.2 to 1.9) 0.79 (0.69 to 0.89) 0.73 (0.59 to 0.83) 6.0 (4.7 to 7.3) 16.6 (13.0 to 20.2) 2.2 (1.7 to 2.6)
Activities of Daily Living 5.1 (1.7 to 8.4) 0.96 (0.95 to 0.98) 0.83 (0.72 to 0.89) 8.7 (6.4 to 11.1) 24.2 (17.7 to 30.7) 3.1 (2.3 to 4.0)
Sport and Recreation Function 8.7 (3.8 to 13.5) 0.88 (0.82 to 0.94) 0.72 (0.57 to 0.82) 12.2 (9.9 to 14.6) 33.8 (27.3 to 40.4) 4.4 (3.6 to 5.3)
Knee-related Quality of Life 4.2 (1.0 to 7.4) 0.90 (0.84 to 0.96) 0.83 (0.73 to 0.89) 8.3 (6.8 to 9.8) 23.1 (19.0 to 27.2) 3.0 (2.5 to 3.5)
KOOS Knee Injury and Osteoarthritis Outcome Score, ICC Intraclass Correlation Coefficient, SEM Standard Error of Measurement, MDC Minimal Detectable Change,
CI Confidence Interval
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response options (VAS vs Likert) are compared rather
than the constructs. Due to overlapping subscales be-
tween the KOOS and WOMAC, it was essential in this
study to compare and correlate the subscales of the
KOOS also with other questionnaire’s subscales asses-
sing similar constructs than those of the WOMAC.
We found, somewhat surprisingly, that the KOOS sub-
scale of Symptoms and the WOMAC subscale of Stiff-
ness showed “only” a moderate correlation. This may
partially be due to fact, as referred to above, that the
KOOS Symptoms subscale contains five items in
addition to the two original WOMAC items, as it also
takes symptoms related to knee movement into account.
Also noteworthy, alongside the KOOS subscales of Pain,
Symptoms and Activities of Daily Living, were the sub-
scales of Sport and Recreation Function and QOL,
which showed a moderate or strong correlation with all
the WOMAC subscales.
When the KOOS and SF-36 were compared for con-
struct validity, we found strong correlations between the
KOOS subscales and those of the SF-36 that measured
similar constructs. The highest correlations were ob-
served between the SF-36 subscale of Physical Function-
ing and the KOOS subscales of ADL and Pain. The
SF-36 subscale of Bodily Pain and the KOOS subscales
of Pain and ADL also showed strong correlations. In
contrast, the KOOS subscale of Symptoms showed the
lowest correlations with all the SF-36 subscales. This is
in line with the findings of Salavati et al. (2008) in pa-
tients with knee injuries, and of Roos et al. (1998) in
subjects with knee OA. In fact, Roos et al. concluded
that the KOOS Symptoms subscale is not as important
as the other four subscales as a determinate of Physical
Health. The authors suggested that symptoms and func-
tional limitations should be reported separately and not
aggregated into a single score [13]. All in all, the con-
struct validity for the patients in our study was at more
or less the same level as observed in patients with knee
injuries [14] and less severe forms of OA [18], but higher
than that obtained in elderly patients with advanced OA
eligible for total joint replacement [15, 34].
The numeric pain rating scale used in this study mea-
sures the intensity of pain experienced in general as well
as in specific body regions. It contains subscales that
make it possible to explore correlations with the KOOS
subscales. As expected, we found strong and moderate
correlations between all the KOOS and Pain-NRS sub-
scales, particularly those focusing on the lower extrem-
ities and the knee region. These findings, in conjunction
with the fact that self-reported knee pain was more se-
vere than pain in any other body region, confirm the
utility of the KOOS as a lower-extremity PRO measure
in subjects with diverse knee problems. Also of note was
the finding of strong correlations between the Pain-NRS
Knee and lower limb subscales and the KOOS Activities
of Daily Living subscale. This is understandable, given
that the knee is a large weight-bearing joint with a large
range of movements, and that managing the activities of
daily living presumes an extensive repertoire of pain-free
weight-bearing movements. However, somewhat surpris-
ingly, the KOOS Pain subscale correlated only strongly
instead of, as expected, very strongly with the Pain-NRS
Knee subscale. This is most likely due to only partial
similarity between the constructs in the two subscales.
While the nine-item KOOS Pain subscale is designed to
elicit the prevalence and degree of pain during different
activities and rest, the Pain-NRS Knee subscale consists
of a single item in asking about the intensity of pain ex-
perienced during the past week. Nevertheless, the use of
the Pain-NRS yielded new information, since to our
knowledge no previous KOOS validation studies have in-
vestigated the correlations between the KOOS and
Pain-NRS subscales. From our pre-defined hypotheses
altogether 89% could be confirmed.
Internal consistency was good for all five subscales,
exceeding the cutoff value of 0.70. This result is compar-
able to observations in other languages and patient pop-
ulations, such as in the Swedish version with
preoperative patients [13], the Dutch version with pa-
tients with focal cartilage defects [37], the Persian ver-
sion with patients with knee injuries [14], and the
Singapore English and Singapore Chinese [15], Dutch
[17], Portuguese [18] and French [16] versions with knee
OA patients. Two recent Polish validation studies with
test-retest intervals of one to 2 weeks found Cronbach’s
αs higher than 0.90 in patients undergoing ACL recon-
struction [38] and total knee replacement [36]. The au-
thors concluded that this might be due to the relative
homogeneity of their patient group. Accordingly, it has
been claimed that, for clinical application, high Cron-
bach’s α values, of at least 0.90, are needed [39]. How-
ever, given that, our Cronbach’s α values were, with the
exception of the Symptoms subscale, all around border-
line significance, we consider them reasonable for clin-
ical purposes. The result of the item analysis also
suggests that all five subscales are acceptable for inclu-
sion in the Finnish version of KOOS.
The ICC values for test-retest reliability for all the
KOOS subscales were good, ranging from 0.72 to 0.86,
thereby indicating sufficient standardization of the
KOOS questionnaire. Overall, our results are compar-
able to those of previous methodological studies of
KOOS [12, 13] and other studies [14, 17–19, 36, 37, 40,
41] where ICC values over 0.70 have indicated good or
excellent test-retest reliability. Noteworthy, the ICC
value for Sport and Recreation Function in our study
was somewhat lower than expected. It is commonly seen
that Sport and Recreation Function has higher ICC value
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than Symptoms [17, 36, 40, 41].We cannot find an exact
reason why Sport and Recreation Function had relatively
low value, but it is possible that some patients may have
changed their activity level during 2 week interval.
The MDC value of 4.4 points at the group level
indicates that the Finnish version of the KOOS has
an ability to detect a minimum change of 4.5 points
between the measurements. The MDC should be
smaller than the minimal important change (MIC),
which is regarded as the smallest change score
needed for the effect to be considered clinically rele-
vant [42]. For the different KOOS subscales a MIC of
8–10 points has been considered to be appropriate
[34]. Thus the Finnish version of the KOOS is applic-
able to detect such a change without difficulties.
However, it is important to note that the mentioned
MDC values apply to patient groups and not to indi-
vidual patients. The MDC values at the individual
level were considerably higher ranging from 16.6 to
33.8 for the different KOOS subscales. The MDC
values in our study are of same magnitude or some-
what higher than those found in two recent studies in
people with OA awaiting arthroplasty [36, 43].
We recognize some limitations of this study. First, our
sample size was rather small. The response rate for the
re-test remained low (~ 45%), meaning that a relatively
small number of participants were investigated. The
reasons why some subjects did not respond to the sec-
ond KOOS questionnaire remain unknown. Neverthe-
less, according to the Consensus-based Standards for the
selection of health status Measurement Instruments
(COSMIN) group [44], the sample size of 50 to 99 is
considered sufficient. Second, participants in the present
study may not represent patients with entire spectrum
of knee OA and some common knee complaints affect-
ing pain, such as patellofemoral pain syndrome, rheuma-
toid arthritis, plica syndrome, Bakers cyst and bursitis.
However, it must be borne in mind that the KOOS
questionnaire is intended to be used particularly for
knee injuries that can result for a variety of reasons,
including OA. In addition, the initial participant
group recruited to this study was representative of
their population, as all knee patients attending the
outpatient clinic were invited to take part to the
study. Third, due to its cross-sectional design, the
responsiveness of the questionnaire was not assessed
in this study, which may limit the instrument’s abil-
ity to detect clinically important changes over time.
For these reasons, we recommend further validation
of this preliminary Finnish version of KOOS and
consideration of its responsiveness with a larger
number of patients with knee complaints, including
patients across the full radiographic spectrum of
knee OA.
Conclusions
This research effort produced an appropriately translated
and culturally adapted version of KOOS. The Finnish
version of KOOS is a reliable and valid measure that can
be applied as a self-report and disease-specific question-
naire for use in middle-aged patients with knee injuries.
The responsiveness of the Finnish version of KOOS in
larger groups of patients with knee complaints remains
to be tested.
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